1231040
1231048
1231051
1231049
The IDM - a cross-faculty, multidisciplinary postgraduate health research institute
Based on the UCT Faculty of Health Sciences campus in a 7,100 sqm state-of-the-art facility, we operate in the fields of infectious diseases and molecular medicine.
Clinical Research
Clinical research relevant to the needs of Africa's people
The IDM influences health policy and practice by translating our scientific discoveries and applying them in various communities; community relationships and trust are critical.
IDM Capacity Building
Capacity building in the IDM
The largest research entity at UCT, the IDM is a national leader in research and health sciences human capital development.
Cell Imaging Microscope
IDM driving world class research
We conduct research at the laboratory-clinic-community interface by engaging a wide range of scientific and clinical disciplines; with 62 consortia linking us with 183 institutions in 22 African countries and 24 countries beyond.

University accredited research institute - Tackling diseases of importance in Africa - Developing people - Impacting health policy and practice

Home > Home

News

Friday, 10 April 2020
Lockdown necessary but more testing crucial

It is easy to throw stones at idiosyncratic bits of South Africa’s COVID-19 lockdown programme, but it was the right move, said the University of Cape Town’s Professor Robin Wood, at a MedicalBrief webinar. Wood repeatedly stressed the need for more testing.

Publication Date:
Thu, 09 Apr 2020 - 16:00
COVID-19 101: Q&A with Prof Ed Rybicki

In times of crisis, the human imagination tends to fluctuate between two extremes: being employed as a powerful tool for survival or wielded as a toxic weapon of destruction. As the COVID-19 pandemic spreads around the globe, leaving economic and social chaos in its wake, we’ve seen countless expressions of both extremes flick across our screens.

Publication Date:
Tue, 07 Apr 2020 - 11:45
Developing a vaccine for COVID-19

As COVID-19 infection and morbidity rates increase around the globe, a number of companies and academic institutions have entered the race to develop a vaccine to protect us from the lethal virus. Creating a vaccine is, however, a complex process and could take several months, if not years.

Publication Date:
Tue, 07 Apr 2020 - 11:30
TB: Scientists know a great deal, but there’s still more to learn

South Africa has one of the highest rates of tuberculosis (TB) infection globally. Almost 400 000 patients are treated for TB annually. It is also the most common cause of death in South Africa.

Publication Date:
Tue, 24 Mar 2020 - 12:30

Pages

TOP